NCT02077062

Brief Summary

Prospective non-randomized trial to study expression of mediators of post hepatectomy liver regeneration (PHLR) and compare with a non-hepatectomy group: a pilot study Background : Experimental studies using post hepatectomy animal models have been used to study the mechanism of liver regeneration. Hepatectomy for various diseases and living donor liver transplant provide a good human model to study in vivo mechanism of liver regeneration. These studies are necessary for the clinical application of the knowledge obtained by animal experiments and will guide further research to develop new modalities for the management of hepatic failure, cirrhosis and cancer. Null hypothesis: Expression of mediators of post hepatectomy liver regeneration (PHLR) is not different between hepatectomy (study group) and non hepatectomy group (control group). Aim: To study the mechanism of post hepatectomy liver regeneration(PHLR) and compare expression of mediators of PHLR between hepatectomy (study group) and a non-hepatectomy group (control group). Patient and method: This prospective non randomized trail will be conducted on two group of patients- hepatectomy (Study) group and non-hepatectomy (control) group and minimum 10 consecutive adult (18 year or more) patients will be recruited in each group according to inclusion and exclusion criteria given below. Informed consent will be obtained from the patients in both the groups. Peripheral (from a forearm vein) venous blood (6 ml) will be collected a day before surgery and at different intervals after surgery (day 1, day 3,7, 2 weeks, 6 weeks and 6 months). A small branch of portal vein will be cannulated a 20 gauge intravenous catheter for measurement of portal pressure and collection of portal venous blood (6 ml) at the start (after entry inside the abdomen) and at the end (before closure of the abdomen). Patients in hepatectomy (study) group will undergo trucut (needle) biopsy from the remnant liver. Mediators of liver regeneration will be measured by standard methods in blood samples from both groups. The liver tissue from study group will also be analysed for factors related to initiation of PHLR.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

February 21, 2014

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 4, 2014

Completed
7.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

August 6, 2021

Status Verified

July 1, 2021

Enrollment Period

8.3 years

First QC Date

February 21, 2014

Last Update Submit

July 30, 2021

Conditions

Keywords

post hepatectomyliver regenerationmediators

Outcome Measures

Primary Outcomes (1)

  • Serum level (in picogram/ml) of IL-1, IL-6, TNF alfa, TNF beta,HGF, GH, Insulin, Glucagon

    change in serum level of mediators from baseline (before surgery)

    Before surgery and day 1, 3,7,14,42 and 180 after surgery

Study Arms (2)

study (hepatectomy) group

patients undergoing hepatectomy for malignant neoplasm

control (non hepatectomy) group

patients undergoing intestinal resections (not incluiding hepatectomy) for malignant neoplasm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

liver regeneration in patient with hepatectomy

You may qualify if:

  • adult (18 year or more)
  • hepatectomy for malignant neoplasm (study group)
  • other GI resections for malignant G I tract tumors
  • willing to participate

You may not qualify if:

  • less than 18 years in age
  • not willing to participate
  • immunosuppression
  • chronic hepatitis
  • cirrhosis
  • portal hypertension
  • pregenancy
  • oral contraceptives

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

G B Pant Hospital

New Delhi, National Capital Territory of Delhi, 110002, India

Location

Study Officials

  • hirdaya h nag, ms

    gobind ballabh pant hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor in G I Surgery

Study Record Dates

First Submitted

February 21, 2014

First Posted

March 4, 2014

Study Start

March 1, 2013

Primary Completion

July 1, 2021

Study Completion

July 1, 2021

Last Updated

August 6, 2021

Record last verified: 2021-07

Locations